IP Library Granted Patent US 10,111,424
Granted Patent B2
US 10,111,424 · App. 14/891,560 · Granted Oct 30, 2018

Release of biologically active agents from polymeric composite particles

Inventors: Hassan Sahouani (Hastings, MN); Mary M. Caruso Dailey (Maplewood, MN); Luke E. Heinzen (Mahtomedi, MN); Ibrahim A. El Hedok (Woodbury, MN)
Assignee: 3M INNOVATIVE PROPERTIES COMPANY
A01N25/26A01N25/10A01N25/28A01N47/44A01N51/00B01J13/043C08J3/126C08J9/16C08J9/286C08J9/365C08J9/40C08J2201/036C08J2201/04C08J2205/024C08J2207/10C08J2333/14C08J2347/00C08J2400/22C08J2491/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,111,424
App. No.
14/891,560
Granted
Oct 30, 2018
Kind
B2
Abstract

Polymeric composite particles are provided that can be used for the storage and delivery of various biologically active agent. The polymeric composite particles contain a porous polymeric core and a coating layer around the porous polymeric core. The porous polymeric composite particles typically further include a biologically active agent positioned within the porous polymeric core but not covalently bonded to the porous polymeric core. The biologically active agent can be released from the polymeric composite particle by diffusing out of the porous polymeric core through the coating layer.

Claims (59)

1. A polymeric composite particle comprising

a) a porous polymeric core particle comprising a washed and dried polymerized product of a reaction mixture comprising:

i) a first phase comprising either

1) water and a polysaccharide dissolved in the water; or

2) a surfactant and a compound of Formula (I)

wherein n is an integer equal to at least 1, or a mixture thereof; and

ii) a second phase dispersed in the first phase, wherein a volume of the first phase is greater than a volume of the second phase and wherein the second phase comprises

1) a monomer composition comprising a first monomer of Formula (II)

wherein

the monomer of Formula (II) is not miscible with the first phase;

p is an integer is no greater than 30;

R 1 is hydrogen or alkyl; and

2) a poly(propylene glycol) having a weight average molecular weight of at least 500 grams/mole,

wherein the poly(propylene glycol) is removed from the polymerized product to provide the porous polymeric core;

b) a biologically active agent positioned within the porous polymeric core, wherein the biologically active agent is not covalently bonded to the porous polymeric core; and

c) a coating layer around the porous polymeric core particle, wherein the coating layer comprises a thermoplastic polymer, a wax, or a mixture thereof.

2. The polymeric composite particle of claim 1 , wherein the polymeric composite particle has a core-shell configuration with the core being the porous polymeric core particle and the shell being the coating layer.

3. The polymeric composite particle of claim 1 , wherein the first phase comprise water and 10 to 30 weight percent polysaccharide based on a total weight of the first phase.

4. The polymeric composite particle of claim 1 , wherein the first phase comprises the compound of Formula (I) and a nonionic surfactant.

5. The polymeric composite particle of claim 1 , wherein the monomer composition comprises a second monomer of Formula (III)

wherein

R 1 is hydrogen or methyl;

Y is a single bond, alkylene, oxyalkylene, or poly(oxyalkylene); and

R 2 is a carbocyclic group or heterocyclic group.

6. The polymeric composite particle of claim 1 , wherein the monomer composition comprises a second monomer of Formula (VII) or a salt thereof

wherein

R 1 is hydrogen or methyl; and

R 6 is an alkylene.

7. The polymeric composite particle of claim 1 , wherein the biologically active agent comprises a herbicide, insecticide, fungicide, or mixture thereof.

8. The polymeric composite particle of claim 1 , wherein the coating layer comprises a silicone-based thermoplastic polymer, (meth)acrylate-based thermoplastic polymer, olefin-based thermoplastic polymer, styrene-based thermoplastic polymer, or a phenoxy-based resin.

9. The polymeric composite particle of claim 1 , wherein the coating layer comprises an animal wax, vegetable wax, petroleum wax, hydrogenate vegetable oil, or polyethylene.

10. The polymeric composite particle of claim 1 , wherein the polymeric composite particle comprises 20 to 90 weight percent porous polymeric core particle, 0.1 to 40 weight percent biologically active agent, and 10 to 80 weight percent coating layer.

11. A method of delivering a biologically active agent, the method comprising:

providing a polymeric composite particle comprising

a) a porous polymeric core particle comprising a washed and dried polymerized product of a reaction mixture comprising:

i) a first phase comprising either

1) water and a polysaccharide dissolved in the water; or

2) a surfactant and a compound of Formula (I)

ii) a second phase dispersed in the first phase, wherein a volume of the first phase is greater than a volume of the second phase and wherein the second phase comprises

1) a monomer composition comprising a first monomer of Formula (II)

wherein

 the monomer of Formula (II) is not miscible with the first phase;

 p is an integer is no greater than 30;

 R 1 is hydrogen or alkyl; and

2) a poly(propylene glycol) having a weight average molecular weight of at least 500 grams/mole,

wherein the poly(propylene glycol) is removed from the polymerized product to provide the porous polymeric core;

b) a biologically active agent positioned within the porous polymeric core, wherein the biologically active agent is not covalently bonded to the porous polymeric core; and

c) a coating layer around the porous polymeric core particle, wherein the coating layer comprises a thermoplastic polymer, a wax, or a mixture thereof; and

releasing the biologically active agent from the polymeric composite particle by diffusion through the coating layer.

12. The method of claim 11 , wherein the first phase comprise water and 10 to 30 weight percent polysaccharide based on a total weight of the first phase.

13. The method of claim 11 , wherein the first phase comprises the compound of Formula (I) and a nonionic surfactant.

14. The method of claim 11 , wherein providing the polymeric composite particle comprises

forming the porous polymeric core particle;

positioning the biologically active agent within the porous polymeric core particle to form a loaded polymeric particle; and

depositing the coating layer around the loaded polymeric particle.

15. The method of claim 14 , wherein depositing the coating layer comprises

preparing a coating solution or a coating dispersion;

mixing the loaded polymeric particle with the coating solution or coating dispersion to form a slurry; and

drying the slurry, wherein drying comprises spray drying or fluidized bed drying.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 16, 2015
From: SAHOUANI, HASSAN; CARUSO DAILEY, MARY M.; HEINZEN, LUKE E.; EL HEDOK, IBRAHIM A.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 037050/0583 →
Continuity (3)
Provisional Application 61990348 · May 8, 2014
Provisional Application 61824412 · May 17, 2013
Related Publication 20160088836A1 · Mar 31, 2016